alpha-Sarcin catalytic activity is not required for cytotoxicity
| dc.contributor.author | Alford, Spencer C. | |
| dc.contributor.author | Pearson, Joel D. | |
| dc.contributor.author | Carette, Amanda | |
| dc.contributor.author | Ingham, Robert J. | |
| dc.contributor.author | Howard, Perry L. | |
| dc.date.accessioned | 2014-07-15T23:49:47Z | |
| dc.date.available | 2014-07-15T23:49:47Z | |
| dc.date.copyright | 2009 | en_US |
| dc.date.issued | 2009-04-03 | |
| dc.description | BioMd Central | en_US |
| dc.description.abstract | Background: α-Sarcin is a protein toxin produced by Aspergillus giganteus. It belongs to a family of cytotoxic ribonucleases that inactivate the ribosome and inhibit protein synthesis. α-Sarcin cleaves a single phosphodiester bond within the RNA backbone of the large ribosomal subunit, which makes the ribosome unrecognizable to elongation factors and, in turn, blocks protein synthesis. Although it is widely held that the protein synthesis inhibition caused by the toxin leads to cell death, it has not been directly shown that catalytically inactive mutants of α-sarcin are non-toxic when expressed directly within the cytoplasm of cells. This is important since recent studies have cast doubt on whether protein synthesis inhibition is sufficient to initiate apoptosis. Results: In this report, we assay α-sarcin cytotoxicity and ability to inhibit protein synthesis by direct cytoplasmic expression. We show that mutations in α-sarcin, which impair α-sarcin's ability to inhibit protein synthesis, do not affect its cytotoxicity. The mutants are unable to activate JNK, confirming that the sarcin-ricin loop remains intact and that the α-sarcin mutants are catalytically inactive. In addition, both mutant and wildtype variants of α-sarcin localize to the nucleus and cytoplasm, where they co-localize with ribosomal marker RPS6. Conclusion: We conclude that although protein synthesis inhibition likely contributes to cell death, it is not required. Thus, our results suggest that α-sarcin can promote cell death through a previously unappreciated mechanism that is independent of rRNA cleavage and JNK activation. | en_US |
| dc.description.reviewstatus | Reviewed | en_US |
| dc.description.scholarlevel | Faculty | en_US |
| dc.description.sponsorship | This work was funded by an NSERC Discovery Grant (PLH) | en_US |
| dc.identifier.citation | Alford et al. Alpha-Sarcin catalytic activity is not required for cytotoxicity. BMC Biochemistry 2009 10:9. | en_US |
| dc.identifier.uri | http://www.biomedcentral.com/1471-2091/10/9 | |
| dc.identifier.uri | http://dx.doi.org/10.1186/1471-2091-10-9 | |
| dc.identifier.uri | http://hdl.handle.net/1828/5459 | |
| dc.language.iso | en | en_US |
| dc.publisher | BioMed Central | en_US |
| dc.subject | Centre for Biomedical Research | |
| dc.subject.department | Department of Biochemistry and Microbiology | |
| dc.subject.department | Department of Biology | |
| dc.title | alpha-Sarcin catalytic activity is not required for cytotoxicity | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Alford_SpencerC_BMCBiochem_2009.pdf
- Size:
- 1.21 MB
- Format:
- Adobe Portable Document Format
- Description:
- Alford_SpencerC_BMCBiochem_2009.pdf
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.74 KB
- Format:
- Item-specific license agreed upon to submission
- Description: